Stimulating neurogenesis of adult neural stem cells by activating death receptor CD95
Optimizing the survival and differentiation of neural stem cells is one of the major goals in stem cell biology today. The present invention achieves this goal by the discovery that the ligand for CD95 (APO-1/Fas), namely, CD95L, induces neuronal differentiation in vitro and in vivo and use of CD95L compositions to effect differentiation. The present invention demon-strates that activation of CD95 can promote neurogenesis in neural stem cells (NSCs) in areas of neuronal damage or injury.
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Bringing bio-inspired robots to life
Nebraska researcher Eric Markvicka gets NSF CAREER Award to pursue manufacture of novel materials for soft robotics and stretchable electronics. Engineers are increasingly eager to develop robots that mimic the…
Bella moths use poison to attract mates
Scientists are closer to finding out how. Pyrrolizidine alkaloids are as bitter and toxic as they are hard to pronounce. They’re produced by several different types of plants and are…
AI tool creates ‘synthetic’ images of cells
…for enhanced microscopy analysis. Observing individual cells through microscopes can reveal a range of important cell biological phenomena that frequently play a role in human diseases, but the process of…
